Literature DB >> 25197829

A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort.

David C Boettiger1, Vonthanak Saphonn, Man Po Lee, Praphan Phanuphak, Thuy Thanh Pham, Benedict Lim Heng Sim, Nagalingeswaran Kumarasamy, Kinh Van Nguyen, Pacharee Kantipong, Adeeba Kamarulzaman, Romanee Chaiwarith, Sasisopin Kiertiburanakul, Matthew G Law.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25197829      PMCID： PMC4213211          DOI： 10.1097/QAI.0000000000000338

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  9 in total

1.  A clinical prediction score for targeted creatinine testing before initiating tenofovir-based antiretroviral treatment in Cambodia.

Authors:  Johan van Griensven; Lay Phirum; Sopheak Thai; Jozefien Buyze; Lutgarde Lynen
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

2.  An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia.

Authors:  Lutgarde Lynen; Sokkab An; Olivier Koole; Sopheak Thai; Seilavath Ros; Paul De Munter; Delphine Sculier; Line Arnould; Katrien Fransen; Joris Menten; Marleen Boelaert; Jef Van den Ende; Robert Colebunders
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

3.  Making better decisions: construction of clinical scoring systems by the Spiegelhalter-Knill-Jones approach.

Authors:  D G Seymour; M Green; F G Vaz
Journal:  BMJ       Date:  1990-01-27

4.  Statistical methodology for evaluating gastrointestinal symptoms.

Authors:  D J Spiegelhalter
Journal:  Clin Gastroenterol       Date:  1985-07

5.  Prognostic indicators of early and late death in children admitted to district hospital in Kenya: cohort study.

Authors:  J A Berkley; A Ross; I Mwangi; F H A Osier; M Mohammed; M Shebbe; B S Lowe; K Marsh; C R J C Newton
Journal:  BMJ       Date:  2003-02-15

6.  Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements.

Authors:  Inmaculada Jiménez-Nácher; Benito García; Pablo Barreiro; Sonia Rodriguez-Novoa; Judit Morello; Juan González-Lahoz; Carmen de Mendoza; Vincent Soriano
Journal:  J Antimicrob Chemother       Date:  2008-06-21       Impact factor: 5.790

7.  The TREAT Asia HIV Observational Database: baseline and retrospective data.

Authors:  Jialun Zhou; N Kumarasamy; Rossana Ditangco; Adeeba Kamarulzaman; Christopher K C Lee; Patrick C K Li; Nicholas I Paton; Praphan Phanuphak; Sanjay Pujari; Asda Vibhagool; Wing-Wai Wong; Fujie Zhang; John Chuah; Kevin R Frost; David A Cooper; Matthew G Law
Journal:  J Acquir Immune Defic Syndr       Date:  2005-02-01       Impact factor: 3.771

8.  Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.

Authors:  Elvin H Geng; Peter W Hunt; Lameck O Diero; Sylvester Kimaiyo; Geofrey R Somi; Pius Okong; David R Bangsberg; Mwebesa B Bwana; Craig R Cohen; Juliana A Otieno; Deo Wabwire; Batya Elul; Denis Nash; Philippa J Easterbrook; Paula Braitstein; Beverly S Musick; Jeffrey N Martin; Constantin T Yiannoutsos; Kara Wools-Kaloustian
Journal:  J Int AIDS Soc       Date:  2011-09-28       Impact factor: 5.396

9.  Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.

Authors:  Raph L Hamers; Rebecca Oyomopito; Cissy Kityo; Praphan Phanuphak; Margaret Siwale; Somnuek Sungkanuparph; Francesca Conradie; Nagalingeswaran Kumarasamy; Mariette E Botes; Thira Sirisanthana; Saade Abdallah; Patrick C K Li; Nicoletta Ngorima; Pacharee Kantipong; Akin Osibogun; Christopher K C Lee; Wendy S Stevens; Adeeba Kamarulzaman; Inge Derdelinckx; Yi-Ming Arthur Chen; Rob Schuurman; Michèle van Vugt; Tobias F Rinke de Wit
Journal:  Int J Epidemiol       Date:  2010-11-10       Impact factor: 7.196
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.